Supplementary Figure 3 Sequential Branch-off De novo * * * * **

Slides:



Advertisements
Similar presentations
Chapter 19 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
Advertisements

Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas: it’s Histopathologic Difference Between 2 Major Types Shinichi Ban, MD,* Yoshihisa Naitoh,
Journal Reading Presented by Dr. 陳志榮. An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal.
1 Breast MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE PANCREAS:
LCC REC-1 Φ π π π Φ Φ See Primary and Adjuvant Treatment (LCC REC-3) Observe or See Primary Treatment (LCC REC-3) Rectal Cancer.
(aa) BTB domain Zinc-finger domains BCL6 Number of samples mutated Number of mutations per 10 amino.
Kyung Hee University, Seoul, Korea GI Conference UGI Conference Presented by Byeong-Joo Noh Supervised by Youn-Wha Kim Kyung Hee University, Seoul, Korea.
R2 최하나. INTRODUCTION Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas –Intraductal proliferation of mucin-producing epithelial cells –Cystic.
Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification R1 김진숙 / Prof. 장재영.
Kyung Hee University, Seoul, Korea GI Conference UGI Conference Presented by Byeong-Joo Noh Supervised by Youn-Wha Kim Kyung Hee University, Seoul, Korea.
Volume 13, Issue 3, Pages (May 2013)
Matthew D. Rutter, Robert H. Riddell 
Fig. 1. Immunohistochemical (IHC) staining of transducer-like enhancer of split 1 (TLE1) in normal gastric mucosa and gastric cancer (GC). (A) Representative.
Diagnosis and Treatment of Cystic Pancreatic Tumors
Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung  Hyo Sup Shim, MD, PhD, Mari- Kenudson, MD, Zongli Zheng,
Gastrointestinal Block Pathology lecture 2016/2017
Thomas Kirchner, Thomas Brabletz  The American Journal of Pathology 
Pancreas Cysts : What Do I Do in My Practice??
Cystic Neoplasms of the Pancreas: A Surgical Perspective
Pancreatic tumour slide seminar
Volume 134, Issue 4, Pages (April 2008)
Evaluation of the Guidelines for Management of Pancreatic Branch-Duct Intraductal Papillary Mucinous Neoplasm  Raymond S. Tang, Benjamin Weinberg, David.
Covering the Cover Gastroenterology
Serrated Colon Polyps as Precursors to Colorectal Cancer
Preinvasive Neoplasia in the Stomach: Diagnosis and Treatment
Reporting precursors to invasive pancreatic cancer: pancreatic intraepithelial neoplasia, intraductal neoplasms and mucinous cystic neoplasm  Roeland.
Corina A. Schmid, Anne Müller  Gastroenterology 
Volume 133, Issue 1, Pages (July 2007)
My Treatment Approach: Pancreatic Cysts
WT G>A G>C G>T (n = 93) (n = 21) (n = 10) (n = 51)
Case: Hippocampal sclerosis
Reporting precursors to invasive pancreatic cancer: pancreatic intraepithelial neoplasia, intraductal neoplasms and mucinous cystic neoplasm  Roeland.
Jens T. Siveke, Roland M. Schmid  Cancer Cell 
MAPing the Role of Kras Mutations in Hyperplastic Polyps
James L. Buxbaum, MD  Clinical Gastroenterology and Hepatology 
Covering the Cover Gastroenterology
KRAS, NRAS, PIK3CA Exon 20, and BRAF Genotypes in Synchronous and Metachronous Primary Colorectal Cancers  Katharina Balschun, Jochen Haag, Ann-Kathrin.
Volume 149, Issue 7, Pages e4 (December 2015)
Volume 154, Issue 3, Pages (February 2018)
Figure 4 Oncogenic KRAS and inflammation
Volume 142, Issue 4, Pages e9 (April 2012)
New Insights Into the Cell Lineage of Pancreatic Ductal Adenocarcinoma: Evidence for Tumor Stem Cells in Premalignant Lesions?  Janel L. Kopp, Maike Sander 
Intraductal Papillary Mucinous Neoplasms of the Pancreas
Volume 155, Issue 3, Pages e2 (September 2018)
Use of Oncogenic Driver Mutations in Staging of Multiple Primary Lung Carcinomas: A Single-Center Experience  Ramsey Asmar, MD, Joshua R. Sonett, MD,
Jean-Charles Nault, Peter R. Galle, Jens U. Marquardt 
Diagnosis and Treatment of Cystic Pancreatic Tumors
Volume 138, Issue 4, Pages e7 (April 2010)
Mucin-Producing Neoplasms of the Pancreas: An Analysis of Distinguishing Clinical and Epidemiologic Characteristics  Stefano Crippa, Carlos Fernández–del.
Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung  Hyo Sup Shim, MD, PhD, Mari- Kenudson, MD, Zongli Zheng,
KLF4 Initiates Acinar Cell Reprogramming and Is Essential for the Early Stages of Pancreatic Carcinogenesis  Ravikanth Maddipati, Jonathan P. Katz  Cancer.
Rushika M. Perera, Nabeel Bardeesy  Cancer Cell 
David Albers, MD, Dani Dakkak, MD  VideoGIE 
Epidermal Growth Factor Receptor Mutation and p53 Overexpression during the Multistage Progression of Small Adenocarcinoma of the Lung  Seol Bong Yoo,
Volume 156, Issue 3, Pages e2 (February 2019)
Colonic polyps and tumors
Gastrointestinal Cancer Imaging: Deeper Than the Eye Can See
Dr. Maha Arafah Dr. Ahmed Al Humaidi
Volume 133, Issue 1, Pages (July 2007)
Supplementary Table S2 Correlation between pre-operative plasma miR-451 or miR-486 concentrations and clinicopathologic features in gastric cancer patients.
Early Detection of Pancreatic Cancer: Opportunities and Challenges
(A) Sequential subtype (B) Branch-off subtype (C) De novo subtype
(histological continuity)
Gross and histologic features of the intestinal neoplasms initiated by the Apc1638N mutation. Gross and histologic features of the intestinal neoplasms.
A and B, images from a patient with an invasive carcinoma on the floor of the mouth. A and B, images from a patient with an invasive carcinoma on the floor.
Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI Using Revised 2017 International Consensus Guidelines.
Distribution of FGFR aberrancies in urothelial cancers.
GCS-100 selectively kills KRAS-addicted lung tumors.
Presentation transcript:

Supplementary Figure 3 Sequential Branch-off De novo * * * * ** Histology of the carcinoma Invasive carcinoma Supplementary Figure 3 Case 5 (16) H i * H Case 6 (2) H * H Case 1 H H Case 2 H Case 3 Annotation box Sequential H Gastric type Intestinal type Pancreatobiliary type Oncocytic feature Case 4 H i Case 30 H L Tubular adenocarcinoma Mucinous adenocarcinoma Case 7 H i i H, L, i, IPMN with high-grade dysplasia IPMN with low-grade dysplasia Incipient IPMN Case 26 H L *, Second metachronous invasive cancer **, Second synchronous invasive cancer //, Margin of the first operation, recurrence case (year), Time to recurrence , Contiguous neoplastic lesion between IPMN and PDA via main pancreatic duct Case 29 H L Case 18 L Case 13 L L L i KRAS WT GNAS WT G12V R201H Case 12 L L i G12D R201C G12R Q227H Case 21 (2) H * H i Q61H/Q61R G12C Case 25 A142T Branch-off L Case 8 TP53 Mutation Aberrant L SMAD4 Mutation Aberrant CDKN2A/p16 Mutation Aberrant Case 11 L i CTNNB1 mutation and/or β-catenin nuclear stain RNF43 mutation and/or loss Case 14 L L Other mutations Case 16 L (Example) TP53 CDKN2A/p16 SMAD4 Case 19 Mutation L IHC Case 24 H L L GNAS Case 23 (1) H L * KRAS Case 17 L i Case 15 L i Case 10 De novo L Case 22 L Case 28 ** L i Case 20 (4) i H L i (10) Case 27 H i H H Case 9 H IPMN subtype 1 2 3 4 5 6 7 8 9 10 Distance from invasive cancer (cm)